Literature DB >> 17413392

Protecting the kidney during critical illness.

Dean R Jones1, H Thomas Lee.   

Abstract

PURPOSE OF REVIEW: Acute renal failure causes considerable morbidity and mortality in critically ill patients. To date, there are few therapies available to clinicians that alter outcome. This review will focus on clinical and basic science research efforts related to the diagnosis, pathophysiology, prevention, and treatment of acute renal failure. RECENT
FINDINGS: The incidence of acute renal failure may be increasing and the mortality rate continues to be significant. The development of sensitive, predictive biomarkers of acute renal failure may help to diagnose the syndrome earlier and allow for meaningful therapeutic intervention. A number of new therapies are in development for acute renal failure. Many show promise in animal models of acute renal failure but prospective studies in humans are lacking.
SUMMARY: Despite the present lack of therapies for the treatment and prevention of acute renal failure, there are reasons to be optimistic. Recent research has led to the development of several different strategies that may provide a breakthrough in the treatment of acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413392     DOI: 10.1097/ACO.0b013e328013f83c

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  11 in total

1.  Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice.

Authors:  Minjae Kim; Sang Won Park; Mihwa Kim; Sean W C Chen; William T Gerthoffer; Vivette D D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-19

2.  Targeting Hypoxia-induced Inflammation.

Authors:  Holger K Eltzschig
Journal:  Anesthesiology       Date:  2011-02       Impact factor: 7.892

3.  Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.

Authors:  Petra Szoleczky; Katalin Módis; Nóra Nagy; Zoltán Dóri Tóth; Douglas DeWitt; Csaba Szabó; Domokos Gero
Journal:  Arch Biochem Biophys       Date:  2011-11-11       Impact factor: 4.013

4.  Suppression of renal TRPM7 may alleviate kidney injury in the renal transplantation.

Authors:  Zhe Meng; Rui Cao; Yongzhi Wang; Hong Cao; Tao Liu; Zhonghua Yang; Xinghuan Wang
Journal:  World J Urol       Date:  2013-11-21       Impact factor: 4.226

5.  Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury.

Authors:  Sang Wong Park; Mihwa Kim; Kevin M Brown; Vivette D D'Agati; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

6.  Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway.

Authors:  H Thomas Lee; Sean W C Chen; Thomas C Doetschman; Chuxia Deng; Vivette D D'Agati; Mihwa Kim
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-23

7.  Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion.

Authors:  Sean W C Chen; Minjae Kim; Mihwa Kim; Joseph H Song; Sang Won Park; Dominic Wells; Kevin Brown; Jacqueline de Belleroche; Vivette D D'Agati; H Thomas Lee
Journal:  Kidney Int       Date:  2008-11-19       Impact factor: 10.612

8.  Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury.

Authors:  Minjae Kim; Sean W C Chen; Sang Won Park; Mihwa Kim; Vivette D D'Agati; Jay Yang; H Thomas Lee
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

9.  Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia.

Authors:  Sang W Park; Mihwa Kim; Joo Y Kim; Kevin M Brown; Volker H Haase; Vivette D D'Agati; H Thomas Lee
Journal:  Kidney Int       Date:  2012-06-13       Impact factor: 10.612

10.  The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury.

Authors:  Mihwa Kim; Ahrom Ham; Joo Y Kim; Kevin M Brown; Vivette D D'Agati; H Thomas Lee
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.